{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:29Z","timestamp":1759333649856},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00105-006-1261-1","type":"journal-article","created":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T08:48:11Z","timestamp":1165913291000},"page":"525-528","source":"Crossref","is-referenced-by-count":11,"title":["Deutliche Besserung eines Skleromyx\u00f6dem Arndt-Gottron durch hoch dosierte intraven\u00f6se Immunglobuline"],"prefix":"10.1007","volume":"58","author":[{"given":"S.","family":"Topf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Simon jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"L\u00fcftl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1261_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 139: 33\u201336","journal-title":"Arch Dermatol"},{"key":"1261_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0190-9622(99)70383-X","volume":"41","author":"Bata-Cs","year":"1999","unstructured":"Bata-Cs\u00f6rg\u00f6 Z, Husz S, Foldes M et al. (1999) Scleromyxoedema. J Am Acad Dermatol 41: 343\u2013346","journal-title":"J Am Acad Dermatol"},{"key":"1261_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(98)70567-5","volume":"38","author":"Godby","year":"1998","unstructured":"Godby A, Bergstresser P, Chaker B, Pandya A (1998) Fatal Scleromyxoedema: report of a case and review of the literature. J Am Acad Dermatol 38: 289\u2013294","journal-title":"J Am Acad Dermatol"},{"key":"1261_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2230.2004.01518.x","volume":"29","author":"Karim","year":"2004","unstructured":"Karim A, Lawlor F, Black M (2004) Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Clin Exp Dermatol 29: 317","journal-title":"Clin Exp Dermatol"},{"key":"1261_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobuline. N Engl J Med 345: 747\u2013755","journal-title":"N Engl J Med"},{"key":"1261_CR6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1365-2133.2003.05682.x","volume":"149","author":"Kulczycki","year":"2003","unstructured":"Kulczycki A, Nelson M, Eisen A, Heffeman M (2003) Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Br J Dermatol 149: 1276\u20131281","journal-title":"Br J Dermatol"},{"key":"1261_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mjd.2000.104001","volume":"43","author":"Lister","year":"2000","unstructured":"Lister RK, Jolles S, Whittaker S et al. (2000) Scleromyxoedema: response to high-dose intravenous immunoglobulin (hdIVIG). J Am Acad Dermatol 43: 403\u2013408","journal-title":"J Am Acad Dermatol"},{"key":"1261_CR8","first-page":"1","volume":"9","author":"Mydlarski","year":"2004","unstructured":"Mydlarski P, Mittmann N, Shear H (2004) Intravenous immunoglobulin: use in dermatology. Skin Therapy Lett 9(5): 1\u20136","journal-title":"Skin Therapy Lett"},{"key":"1261_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.61.1.59","volume":"61","author":"Righi","year":"2002","unstructured":"Righi A, Schiavon F, Jablonska S et al. (2002) Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 61: 59\u201361","journal-title":"Ann Rheum Dis"},{"key":"1261_CR10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1067\/mjd.2001.112325","volume":"44","author":"Ruetter","year":"2001","unstructured":"Ruetter A, Luger T (2001) High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol 44: 1010\u20131024","journal-title":"J Am Acad Dermatol"},{"key":"1261_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00128071-200405030-00003","volume":"5","author":"Ruetter","year":"2004","unstructured":"Ruetter A, Luger T (2004) Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease. Am J Clin Dermatol 5: 153\u2013160","journal-title":"Am J Clin Dermatol"},{"key":"1261_CR12","first-page":"152","volume":"45","author":"Schirren","year":"1992","unstructured":"Schirren C, Betke M, Eckert F, Przybilla B (1992) Skleromyx\u00f6dem Arndt-Gottron. Hautarzt 45: 152\u2013157","journal-title":"Hautarzt"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1261-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-006-1261-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1261-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:13Z","timestamp":1558568233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-006-1261-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s00105-006-1261-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}